Trial · NCT07596342
Registered outcomes24
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 24 of 24
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Average sleep latency during the Maintenance of Wakefulness Test | On the day after enrollment ( Day 1) | |
| Secondary | Analgesic consumption | From the day after enrollment (Day 1) to two days after enrollment (Day 2) | Morphine equivalent quantification of analgesic consumption (mg) over the 24 hours following the study night. |
| Secondary | Participation in rehabilitation | From the day after enrollment (Day 1) to two days after enrollment (Day 2) | Assessment of rehabilitation participation by the physiotherapy team using a visual analog scale. min : 0 max : 100 Higher is a better outcome |
| Secondary | Adverse event assessment | From the day of enrollment (Day 0) to the end of follow-up (Day 2) | All adverse events will be recorded during the study with special attention to potential side effects of GHB |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07596342/registered?page=2